H
HERON THERAPEUTI
NASDAQ: HRTX (Heron Therapeutics, Inc.)
Kemas kini terakhir: semalam, 9:17PM1.39
0.12 (9.45%)
| Penutupan Terdahulu | 1.27 |
| Buka | 1.28 |
| Jumlah Dagangan | 7,592,872 |
| Purata Dagangan (3B) | 1,891,808 |
| Modal Pasaran | 254,873,904 |
| Harga / Jualan (P/S) | 1.26 |
| Harga / Buku (P/B) | 32.37 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2025 |
| Margin Keuntungan | -5.24% |
| Margin Operasi (TTM) | 8.11% |
| EPS Cair (TTM) | -0.050 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 12.20% |
| Nisbah Semasa (MRQ) | 2.40 |
| Aliran Tunai Operasi (OCF TTM) | -21.88 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -26.09 M |
| Pulangan Atas Aset (ROA TTM) | -0.99% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Heron Therapeutics, Inc. | Menaik | Menaik |
AISkor Stockmoo
-0.1
| Konsensus Penganalisis | 3.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 0.5 |
| Purata | -0.13 |
|
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.70% |
| % Dimiliki oleh Institusi | 82.47% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Clearline Capital Lp | 30 Sep 2025 | 9,712,527 |
| Palisade Capital Management, Lp | 30 Sep 2025 | 7,327,447 |
| Tejara Capital Ltd | 30 Sep 2025 | 4,589,715 |
| Jw Asset Management, Llc | 30 Sep 2025 | 3,292,633 |
| Julat 52 Minggu | ||
| Median | 6.00 (331.66%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 09 Jan 2026 | 6.00 (331.65%) | Beli | 1.39 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |